TABLE 2.
MLS resistance genotype (no. of isolates) and antibiotic | MIC (μg/ml)a
|
|||
---|---|---|---|---|
Range | 50% | 90% | Geometric mean | |
erm(B) and mef(A) negative (125) | ||||
Penicillin | 0.008–4 | 0.03 | 1 | 0.06 |
Cefotaxime | 0.004–1 | 0.01 | 0.25 | 0.02 |
Telithromycin | 0.002–0.06 | 0.01 | 0.06 | 0.01 |
Erythromycin | 0.008–2 | 0.03 | 0.06 | 0.02 |
Clindamycin | 0.008–0.12 | 0.03 | 0.06 | 0.03 |
Quinupristin-dalfopristin | 0.06–4 | 1 | 2 | 0.9 |
Levofloxacin | 0.12–1 | 1 | 1 | 0.65 |
erm(B) positive and mef(A) negative (73) | ||||
Penicillin | 0.01–4 | 0.5 | 2 | 0.45 |
Cefotaxime | 0.008–1 | 0.25 | 1 | 0.15 |
Telithromycin | 0.004–1 | 0.03 | 0.12 | 0.03 |
Erythromycin | 0.5–>64 | >64 | >64 | 45.0 |
Clindamycin | 0.06–>64 | 64 | >64 | 18.7 |
Quinupristin-dalfopristin | 0.25–8 | 1 | 2 | 0.90 |
Levofloxacin | 0.25–8 | 0.5 | 1 | 0.57 |
erm(B) negative and mef(A) positive (4) | ||||
Penicillin | 0.03–2 | 0.17 | ||
Cefotaxime | 0.008–0.25 | 0.06 | ||
Telithromycin | 0.01–0.5 | 0.09 | ||
Erythromycin | 0.5–8 | 2.82 | ||
Clindamycin | 0.03–0.06 | 0.04 | ||
Quinupristin-dalfopristin | 1–2 | 1.68 | ||
Levofloxacin | 0.25–2 | 0.84 | ||
erm(B) and mef(A) positive (1) | ||||
Penicillin | 0.5 | |||
Cefotaxime | 0.12 | |||
Telithromycin | 0.06 | |||
Erythromycin | 64 | |||
Clindamycin | >64 | |||
Quinupristin-dalfopristin | 2 | |||
Levofloxacin | 1 |
50% and 90%, MICs at which 50 and 90% of isolates are inhibited, respectively.